Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab
Go back to Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 +1.57 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1181.89 | 52 Week High | $88.16 | |||
| Open | $1185.32 | 52 Week Low | $67.88 | |||
| Day High | $1190.00 | P/E | 273.95 | |||
| Day Low | $1160.84 | EPS | $4.32 | |||
| Volume | 1,924,379 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.67 +0.26 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.41 | 52 Week High | $37.39 | |||
| Open | $28.45 | 52 Week Low | $28.25 | |||
| Day High | $28.69 | P/E | 17.38 | |||
| Day Low | $28.17 | EPS | $1.65 | |||
| Volume | 27,761,324 | |||||
